If you’re worried about the extra fat deposited under your chin that just wouldn’t disappear, then here’s a good news for you. The FDA, US has recently given its approval to the Kybella injections for the use in submental fat reduction that collects to form a double chin.
A huge population, especially with the recent changes in lifestyle, is suffering from the double chin trouble. Even slim boys and girls in twenties can gain these ugly double chins as easily as anyone else. Hence, Kybella injection might prove a significant advancement in the field of cosmetic surgery.
What is Kybella Injection?
Kybella is basically composed of deoxycholic acid which is known to dissolve fat. The use of Kybella in the injective form as allowed the people with double chins to get rid of it even without undergoing a surgery. The drug once injected destroys the cell membranes causes them to burst and thus get rid of the fat.
— Idolreplicas.com (@zigverve) September 9, 2015
Who can take benefit of it?
Well, the treatment works wonder on anyone who suffers from double chin as a result of genetics, obesity or age. Even slim women tend to suffer from double chins more often than the males. Thus, those who have a double chin and don’t want to spend a huge sum on liposuction or getting a surgery can take the advantage of Kybella and see their double chin vanish.
What is the process?
The chin area is anaesthetized before beginning. Then, Kybella (deoxycholic acid) is injected in the adipose tissues of the chin areas. Several injections are given separated by one to two centimeters. In a single setting around fifty injections can be given and under a month’s span five of such sitting can be taken. The total number required sitting depends on the individual.
Clinical Trial results
FDA only approved the use of Kybella Injection after establishing its safety and effectiveness. Two clinical trials have been held consisting of 1022 participants with moderate to severe fat deposits under the chin. The participants were either given Kybella injections or placebo based on a random selection for a total of six sittings. According to the trial results, the submental fat was significantly reduced in participants receiving Kybella in comparison to those who received placebo.
Common side effects consists of swelling, bruising, numbness, pain and development of firm area at the injection sites.
Serious side-effects may include injury to the marginal mandibular nerve which is responsible for facial expressions. The injury may lead to a distorted smile. However, it resolves with time. About 4% of the trial participants suffered from this side effect, eventually everyone recovered from it.